Global Mycoplasma Testing Market
Healthcare Services

Global Mycoplasma Testing Market Size, Forecasts, And Opportunities

Learn about the global mycoplasma testing market through The Business Research Company, which provides information on mycoplasma testing market size, mycoplasma testing market drivers and restraints, mycoplasma testing market players, the COVID-19 impact on the mycoplasma testing market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global mycoplasma testing market is expected to grow from $0.64 billion in 2020 to $0.72 billion in 2021 at a compound annual growth rate (CAGR) of 12.4%. The growth is mainly due to a growing demand for these types of tests owing to an increase in spread of mycoplasma pneumonia. The mycoplasma testing market is expected to reach $1.14 billion in 2025 at a CAGR of 12.38%.

The prevalence of mycoplasma pneumonia co-infection among patients with COVID-19 is expected to drive innovation in mycoplasma testing, thus driving the market during the forecast period.

Request A Sample For The Global Mycoplasma Testing Market Report:

The mycoplasma testing market consists of sales of mycoplasma testing services and related products by entities (organizations, sole traders, and partnerships) that provide mycoplasma testing to detect mycoplasma pneumoniae, which causes mycoplasma pneumonia. Mycoplasma pneumonia is a contagious respiratory infection that spreads easily through contact with respiratory fluids. It can cause epidemics. Mycoplasma testing includes a group of tests that measures antibodies in the blood produced in response to a mycoplasma infection and detects the microbe directly through detecting or culturing its genetic material (DNA) in a body sample.

Global mycoplasma testing market segments include:

By Product: Instruments, Assay, Kits, and Reagents

By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies

By Application: Cell Line Testing, Virus Testing, End-of-Production Cell Testing

By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the mycoplasma testing market in 2020.

Major players operating in the market are undertaking various strategic investments such as the launch of innovative products, research and development advancements, and technological innovations, which are gaining significant popularity in the mycoplasma testing market. Companies are introducing new innovative products to meet the requirements of end-users and expand the consumer base to survive in the competitive business environment.

TBRC’s mycoplasma testing market report covers:

Major Market Players: Thermo Fisher Scientific Inc., Merck KGaA, Lonza, PromoCell GmbH, American Type Culture Collection, Charles River Laboratories International Inc., Bionique Testing Laboratories Inc., Biological Industries Israel Beit Haemek Ltd., InvivoGen, Agilent Technologies, Abbott, Roche Diagnostics, Boston Scientific Corporation, Clongen Laboratories LLC, Creative Bioarray, Nelson Laboratories Fairfield Inc., Norgen Biotek Corporation, Biotools B & M Labs S.A, GenBio, GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc., AngioDynamics, AtriCure Inc., CONMED Corporation, Olympus Corporation, Smith & Nephew, and Advanced Cardiac Therapeutics.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Mycoplasma Testing Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides mycoplasma testing market overviews, analyzes and forecasts market size, share, mycoplasma testing market players, mycoplasma testing market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s mycoplasma testing market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Antimicrobial Susceptibility Testing Global Market Report 2021

Analytical Standards Global Market Report 2021

Laboratory Automation Systems Global Market Report 2021

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293


Follow us on LinkedIn:

Follow us on Twitter:

Check out our Blog:

Check out our Global Market Model:

Leave a Reply

Your email address will not be published. Required fields are marked *